AREV Life Sciences Global Corp. (AREVF)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: Jan 29, 2026
AREV Life Sciences Global Revenue
AREV Life Sciences Global had revenue of 7.21K CAD in the twelve months ending September 30, 2023, down -96.08% year-over-year. In the year 2022, AREV Life Sciences Global had annual revenue of 49.11K, down -80.74%.
Revenue (ttm)
7.21K CAD
Revenue Growth
-96.08%
P/S Ratio
2.98
Revenue / Employee
3.60K CAD
Employees
2
Market Cap
15.88K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 49.11K | -205.88K | -80.74% |
| Dec 31, 2021 | 255.00K | 64.42K | 33.80% |
| Dec 31, 2020 | 190.58K | -4.11K | -2.11% |
| Dec 31, 2019 | 194.69K | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MPX International | 5.36M |
| Evergreen Sustainable Enterprises | 2.60M |
| EVIO, Inc. | 2.36M |
| Marijuana Company of America | 1.50M |
| Veritas Farms | 883.65K |
| Aeolus Pharmaceuticals | 771.00K |
| CaliPharms | 112.47K |